A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection

NCT01220947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Copegus
DRUG: Danoprevir
DRUG: Danoprevir
DRUG: Danoprevir
DRUG: Pegasys
DRUG: Ritonavir

Sponsor

Hoffmann-La Roche